Carlyle (CG) EBITDA (2016 - 2026)
Carlyle has reported EBITDA over the past 15 years, most recently at $500.1 million for Q4 2025.
- For Q4 2025, EBITDA rose 69.58% year-over-year to $500.1 million; the TTM value through Dec 2025 reached $1.3 billion, down 15.29%, while the annual FY2025 figure was $1.3 billion, 6010.0% up from the prior year.
- EBITDA for Q4 2025 was $500.1 million at Carlyle, up from $115.6 million in the prior quarter.
- Over five years, EBITDA peaked at $1.3 billion in Q2 2021 and troughed at -$810.7 million in Q4 2023.
- A 5-year average of $407.2 million and a median of $310.8 million in 2022 define the central range for EBITDA.
- Biggest five-year swings in EBITDA: plummeted 505.55% in 2023 and later skyrocketed 734.1% in 2024.
- Year by year, EBITDA stood at $946.1 million in 2021, then plummeted by 78.87% to $199.9 million in 2022, then plummeted by 505.55% to -$810.7 million in 2023, then skyrocketed by 136.38% to $294.9 million in 2024, then soared by 69.58% to $500.1 million in 2025.
- Business Quant data shows EBITDA for CG at $500.1 million in Q4 2025, $115.6 million in Q3 2025, and $468.6 million in Q2 2025.